Patents by Inventor Astrid Alexandra RUEFLI-BRASSE

Astrid Alexandra RUEFLI-BRASSE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY WITH A BET INHIBITOR AND A PROTEASOME INHIBITOR
    Publication number: 20210023099
    Abstract: The present invention is directed to the combination therapy, in particular of multiple myeloma, with a BET inhibitor and a proteasome inhibitor.
    Type: Application
    Filed: October 15, 2020
    Publication date: January 28, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Mark D. Demario, Thomas Friess, Astrid Alexandra Ruefli-Brasse
  • COMBINATION THERAPY WITH A BET INHIBITOR, A BCL-2 INHIBITOR AND AN ANTI-CD20 ANTIBODY
    Publication number: 20200237905
    Abstract: The present invention is directed to the combination therapy of DLBCL with a BET inhibitor, a Bcl-2 inhibitor and an anti-CD20 antibody.
    Type: Application
    Filed: January 24, 2020
    Publication date: July 30, 2020
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Mark D. DEMARIO, Thomas FRIESS, Astrid Alexandra RUEFLI-BRASSE
  • COMBINATION THERAPY WITH A BET INHIBITOR AND A BCL-2 INHIBITOR
    Publication number: 20200237779
    Abstract: The present invention is directed to the combination therapy of multiple myeloma with a BET inhibitor and a Bcl-2 inhibitor.
    Type: Application
    Filed: January 24, 2020
    Publication date: July 30, 2020
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Mark D. DEMARIO, Thomas FRIESS, Astrid Alexandra RUEFLI-BRASSE